Title: Are Biotech Companies Strong Investments?, 4p.

The Q2 2019 initial public offerings (IPOs) market has heated up after a Q1 2019 slowdown partially driven by the longest government shutdown in U.S. history. Ernst and Young reported that 205 IPOs were executed in 2018 on the New York Stock Exchange (NYSE) and Nasdaq, raising almost $53 billion of capital. The biotechnology sector was represented well: EvaluatePharma tabulated 68 biotech IPOs in 2018, raising more than $7 billion of capital. The dramatic increase in biotech capital raised via IPO since 2016 can be seen

Click Here For Complete Article Text


   Person Information
   Application Sequencing
 541711 - Research and Development in Biotechnology                
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor
  • Biotechnology






  • 5/3/2019


  • Article